Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies.
Sagi-Dain LenaLital Cohen VigSarit KahanaShiri YacobsonTamar TenneIfat Agmon-FishmanCochava KleinReut MatarLina Basel-SalmonIdit MayaPublished in: Genetics in medicine : official journal of the American College of Medical Genetics (2019)
Clinically significant CMA aberrations are detected in 1 of 71 pregnancies with normal ultrasound, and in 1 of 131 women with no indication for invasive testing. Thus, CMA might be recommended a first-tier test in pregnancies with normal ultrasound.